Literature DB >> 30615257

Polymer scaffold architecture is a key determinant in mast cell inflammatory and angiogenic responses.

Daniel Abebayehu1, Andrew J Spence2, Michael J McClure1, Tamara T Haque2, Kevin O Rivera2, John J Ryan2.   

Abstract

Implanted polymer scaffolds can induce inflammation leading to the foreign body response (FBR), fibrosis, and implant failure. Thus, it is important to understand how immune cells interact with scaffolds to mitigate inflammation and promote a regenerative response. We previously demonstrated that macrophage phenotype is modulated by fiber and pore diameters of an electrospun scaffold. However, it is unclear if this effect is consistent among other innate immune cells. Mast cells are inflammatory sentinels that play a vital role in the FBR of implanted biomaterials, as well as angiogenesis. We determined if altering electrospun scaffold architecture modulates mast cell responses, with the goal of promoting regenerative cell-scaffold interactions. Polydioxanone (PDO) scaffolds were made from 60 mg/mL or 140 mg/mL PDO solutions, yielding structures with divergent fiber and pore diameters. Mouse mast cells plated on these scaffolds were activated with IL-33 or lipopolysaccharide (LPS). Relative to the 60 mg/mL scaffold, 140 mg/mL scaffolds yielded less IL-6 and TNF, and greater VEGF secretion. Pores >4-6 μm elicited less IL-6 and TNF secretion. IL-33-induced VEGF regulation was more complex, showing effects of both pore size and fiber diameter. These data indicate parameters that can predict mast cell responses to scaffolds, informing biomaterial design to increase wound healing and diminish implant rejection.
© 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 884-892, 2019. © 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  angiogenesis; inflammation; mast cell; polydioxanone

Mesh:

Substances:

Year:  2019        PMID: 30615257      PMCID: PMC6551205          DOI: 10.1002/jbm.a.36605

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  42 in total

Review 1.  Plasma fibronectin concentration: a risk factor for arterial thrombosis?

Authors:  Deane F Mosher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-06       Impact factor: 8.311

Review 2.  Macrophage activation and polarization.

Authors:  Fernando Oneissi Martinez; Antonio Sica; Alberto Mantovani; Massimo Locati
Journal:  Front Biosci       Date:  2008-01-01

3.  Role of plasma fibronectin in the foreign body response to biomaterials.

Authors:  Benjamin G Keselowsky; Amanda W Bridges; Kellie L Burns; Ciara C Tate; Julia E Babensee; Michelle C LaPlaca; Andrés J García
Journal:  Biomaterials       Date:  2007-05-03       Impact factor: 12.479

Review 4.  Effects of biomaterial-induced inflammation on fibrosis and rejection.

Authors:  Kim S Jones
Journal:  Semin Immunol       Date:  2008-01-11       Impact factor: 11.130

Review 5.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

Review 6.  Science of nanofibrous scaffold fabrication: strategies for next generation tissue-engineering scaffolds.

Authors:  Parthasarathy A Madurantakam; Christopher P Cost; David G Simpson; Gary L Bowlin
Journal:  Nanomedicine (Lond)       Date:  2009-02       Impact factor: 5.307

7.  Fibronectin growth factor-binding domains are required for fibroblast survival.

Authors:  Fubao Lin; Xiang-Dong Ren; Zhi Pan; Lauren Macri; Wei-Xing Zong; Marcia G Tonnesen; Miriam Rafailovich; Dafna Bar-Sagi; Richard A F Clark
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

8.  Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase.

Authors:  T Ishizuka; F Okajima; M Ishiwara; K Iizuka; I Ichimonji; T Kawata; H Tsukagoshi; K Dobashi; T Nakazawa; M Mori
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

Review 9.  Mast cells and angiogenesis.

Authors:  Klas Norrby
Journal:  APMIS       Date:  2002-05       Impact factor: 3.205

Review 10.  Mast cells and angiogenesis.

Authors:  Yuji Hiromatsu; Shuji Toda
Journal:  Microsc Res Tech       Date:  2003-01-01       Impact factor: 2.769

View more
  6 in total

Review 1.  Mast Cell-Biomaterial Interactions and Tissue Repair.

Authors:  Emily W Ozpinar; Ariana L Frey; Glenn Cruse; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2021-01-21       Impact factor: 6.389

Review 2.  Control of innate immune response by biomaterial surface topography, energy, and stiffness.

Authors:  Jefferson O Abaricia; Negin Farzad; Tyler J Heath; Jamelle Simmons; Lais Morandini; Rene Olivares-Navarrete
Journal:  Acta Biomater       Date:  2021-04-18       Impact factor: 10.633

3.  TNF-α and INF-γ primed canine stem cell-derived extracellular vesicles alleviate experimental murine colitis.

Authors:  Ju-Hyun An; Qiang Li; Dong-Ha Bhang; Woo-Jin Song; Hwa-Young Youn
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

Review 4.  Cell-Seeded Biomaterial Scaffolds: The Urgent Need for Unanswered Accelerated Angiogenesis.

Authors:  Hanieh Shokrani; Amirhossein Shokrani; S Mohammad Sajadi; Farzad Seidi; Amin Hamed Mashhadzadeh; Navid Rabiee; Mohammad Reza Saeb; Tejraj Aminabhavi; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2022-03-12

Review 5.  The Emerging Role of Immune Cells and Targeted Therapeutic Strategies in Diabetic Wounds Healing.

Authors:  Jianying Song; Lixin Hu; Bo Liu; Nan Jiang; Houqiang Huang; JieSi Luo; Long Wang; Jing Zeng; Feihong Huang; Min Huang; Luyao Cai; Lingyu Tang; Shunli Chen; Yinyi Chen; Anguo Wu; Silin Zheng; Qi Chen
Journal:  J Inflamm Res       Date:  2022-07-20

6.  Evaluation of Polycaprolactone Electrospun Nanofiber-Composites for Artificial Skin Based on Dermal Fibroblast Culture.

Authors:  Morshed Khandaker; Hembafan Nomhwange; Helga Progri; Sadegh Nikfarjam; Melville B Vaughan
Journal:  Bioengineering (Basel)       Date:  2022-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.